Harm Reduction Publications

2024

Brooks HL, Speed KA, Dong K, Salvalaggio G, Pauly BB, Taylor M, Hyshka E. (2024). Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital. PLoS One. 19(2):e0297584.

2023

Morris H, Wild TC, Giovannoni M, Haines-Saah R, Koziel J, Schulz P, Bwala H, Kunyk D, Bubela T, Hyshka E. (2023). Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis. PLoS One. 18(11):e0294608.
Salvalaggio G, Brooks H, Caine V, Gagnon M, Godley J, Houston S, Kennedy MC, Kosteniuk B, Livingston J, Saah R, Speed K, Urbanoski K, Werb D, Hyshka E. (2023). Flawed reports can harm: the case of supervised consumption services in Alberta. Can J Public Health. 114(6):928-933.
Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D. (2023). Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis. Int J Drug Policy. 120:104157.
Galarneau LR, Speed K, Taylor M, Hyshka E. (2023). Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic. Can J Public Health. 114(5):787-795.
Morris H, Bwala H, Wesley J, Hyshka E. (2023). Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces. Can J Public Health. 114(3):484-492.
Morris H, Wild TC, Giovannoni M, Haines-Saah R, Koziel J, Schulz P, Bwala H, Kunyk D, Bubela T, Hyshka E. (2023). Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis. PLoS One. 18(11):e0294608.
Tung M, Jackson J, Ferreira C, Hayden K.A., Ens T. (2023). Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use. International Journal of Drug Policy. Volume 120, 104183.
Jackson J, Colborne M, Gadimova F, Kennedy M.C. (2023). “They talk to me like a person”: Experiences of People in an Injectable Opioid Agonist Treatment Program: A Qualitative Interpretive Description. Journal of Addictions Nursing. 34(3):p 166-172.

2022

Gehring ND, Speed KA, Launier K, O’Brien D, Campbell S, Hyshka E. (2022). The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature. Int J Drug Policy. 102:103589. doi: 10.1016/j.drugpo.2022.103589.
Addorisio S, Kamel MM, Westenberg JN, Heyd A, Maragha T, Abusamak M, Wild TC, Jang KL, Krausz RM.Soc Psychiatry Psychiatr Epidemiol. (2022). Unmet service needs and barriers to care of individuals experiencing absolute homelessness in Edmonton, Canada: a cross-sectional survey. 57(2):387-395. doi: 10.1007/s00127-021-02080-2.
Salvalaggio G, Dong KA, Hyshka E, McCabe C, Nixon L, Rosychuk RJ, Dmitrienko K, Krajnak J, Mrklas K, Wild TC. (2022). Impact of an addiction medicine consult team intervention in a Canadian inner city hospital on acute care utilization: a pragmatic quasi-experimental study. Subst Abuse Treat Prev Policy. 17(1):20. doi: 10.1186/s13011-022-00445-7.

2021

Kosteniuk B, Salvalaggio G, McNeil R, Brooks HL, Dong K, Twan S, Brouwer J, Hyshka E. (2021). “You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care. Int J Drug Policy. 96:103275. doi: 10.1016/j.drugpo.2021.103275.
Biggar E, Papamihali K, Leclerc P, Hyshka E, Graham B, Taylor M, Payer D, Maloney-Hall B, Buxton JA. (2021). Towards cross-Canada monitoring of the unregulated street drug supply. BMC Public Health. 2021 Sep 15;21(1):1678. doi: 10.1186/s12889-021-11757-x.
Kosteniuk B, Salvalaggio G, Wild TC, Gelberg L, Hyshka E. (2021). Perceived unmet substance use and mental health care needs of acute care patients who use drugs: A cross-sectional analysis using the Behavioral Model for Vulnerable Populations. Drug Alcohol Rev. doi: 10.1111/dar.13417.
People with Lived Expertise of Drug Use National Working Group et al. (2021). Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction. Harm Reduct J. 18:1.
Wild TC, Koziel J, Anderson-Baron J, Asbridge M, Belle-Isle L, Dell C, Elliott R, Hathaway A, MacPherson D, McBride K, Pauly B, Strike C, Galovan A, Hyshka E. (2021). Public support for harm reduction: A population survey of Canadian adults. PLoS One. 16(5):e0251860. doi: 10.1371/journal.pone.0251860.

2020

Dong KA, Brouwer J, Johnston C, Hyshka E. (2020). Supervised consumption services for acute care hospital inpatients. CMAJ. 192:E476-9. DOI: 10.1503/cmaj.191365.

2019

Brooks HL, O’Brien D, Salvalaggio G, Dong K, Hyshka E. (2019). Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs. Drug & Alcohol Review.
Hyshka, E., Anderson-Baron, J., Pugh, A., Belle-Isle, L., Hathaway, A., Pauly, B., . . . Wild, T. (2019). Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada. International Journal of Drug Policy. 71, 142-149.
Hyshka, E., Morris, H., Anderson-Baron, J., Nixon, L., Dong, K., & Salvalaggio, G. (2019). Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug and Alcohol Dependence. 204, 107523.
O’Brien, D. C., Dabbs, D., Dong, K., Veugelers, P. J., & Hyshka, E. (2019). Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: A retrospective chart review. BMC Health Services Research. 19(1), 1-12.
Wild, C., Kozie, J., Anderson-Barron, J., Hathaway, J., McCurdy, A., Xu, X., . . . Hyshka, E. (2019). Media coverage of harm reduction, 2000-2016: A content analysis of tone, topics, and interventions in Canadian print news. Drug and Alcohol Dependence. 205, 107599.

2018

Brooks HL, Kassam S, Salvalaggio G, Hyshka E. (2018). Implementing managed alcohol programs in hospital settings: A review of academic and grey literature. Drug Alcohol Rev. 37 Suppl 1:S145-S155.

2017

Hyshka, E., Anderson-Baron,J., Karekezi, K., Belle-Isle, L., Elliott, R., Pauly, B., Strike, C., Asbridge, M., Dell, C., McBride, K., Hathaway, A., & Wild, T.C. (2017). Harm reduction in name but not substance: A comparative analysis of Canadian provincial and territorial policy frameworks. Harm Reduction Journal, 14,50.
Wild, T., Pauly, B., Belle-Isle, L., Cavalieri, W., Elliott, R., Strike, C., Tupper, K., Hathaway, A., Dell, C., MacPherson, D., Sinclair, C., Karekezi, K., Tan, B., Hyshka, E. (2017) Canadian Harm Reduction Policies: A Comparative Content Analysis of Provincial and Territorial Documents, 2000-2015”. International Journal of Drug Policy. 45, 9-17.

2013

Hyshka E, Bubela T, Wild TC. (2013). Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making. Addiction. 108(3), 468-76.

2012

Hyshka E, Strathdee S, Wood E, Kerr T. (2012). Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 23(4), 261-70.

2010

C. Dell, T. Lyons, K. Cayer. (2010). The Role of ‘Kijigabandan’ and ‘Manadjitowin’ in Understanding Harm Reduction Policies and Programs for Aboriginal Peoples. Native Social Work Journal. 7, pp. 109-138.

1999

Wild TC. (1999). Compulsory substance-user treatment and harm reduction: a critical analysis. Subst Use Misuse. 34(1), 83-102.